v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Operating Activities:    
Net loss $ (10,492,384) $ (12,266,429)
Adjustment to reconcile net loss to net cash used in operating activities:    
Stock-based compensation expense 2,697,158 2,704,372
Issuance of restricted shares in exchange for services 138,500 0
Interest accrued on license payable 10,125 10,125
Changes in operating assets and liabilities:    
Prepaid assets and other current assets 161,896 370,375
Other assets 0 110,548
Accounts payable (473,399) 1,130,116
Accrued compensation (201,563) 499,669
Other accrued expenses (1,262,783) (1,351,277)
Net cash used in operating activities (9,422,450) (8,792,501)
Financing Activities:    
Proceeds from sale of shares under At-the-Market Facility, net 1,251,213 0
Payment of taxes from withholding of common stock on settlement of restricted stock units (527,716) 0
Proceeds from issuance of shares of common stock under June 2025 Private Placement, net of issuance costs of $43,933 0 4,621,546
Proceeds from issuance of shares of common stock under the Committed Equity Facility, net of issuance costs of $343,848 0 2,163,100
Proceeds from the exercise of stock options 0 34,115
Deferred offering costs (34,629) (175,226)
Net cash provided by financing activities 688,868 6,643,535
Net change in cash and cash equivalents (8,733,582) (2,148,966)
Cash and cash equivalents, beginning of period 13,159,423 8,641,622
Cash and cash equivalents, end of period 4,425,841 6,492,656
Supplemental disclosure of cash flow information:    
Cash paid for interest 0 0
Cash paid for income taxes 800 800
Supplemental Schedule of Noncash Financing Activities:    
Deferred offering costs charged against At-the-Market Facility 1,622 0
Deferred offering costs, unpaid and accrued 25,900 119,710
Deferred offering costs charged against Committed Equity Facility $ 0 $ 14,594